Atossa Ebitda from 2010 to 2024

ATOS Stock  USD 1.28  0.01  0.78%   
Atossa Genetics EBITDA yearly trend continues to be comparatively stable with very little volatility. EBITDA is likely to outpace its year average in 2024. From the period from 2010 to 2024, Atossa Genetics EBITDA quarterly data regression had mean square error of 17.1 T and mean deviation of  7,555,253. View All Fundamentals
 
EBITDA  
First Reported
2009-09-30
Previous Quarter
-7.1 M
Current Value
-6.4 M
Quarterly Volatility
2.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Atossa Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Atossa Genetics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 21.9 K, Interest Expense of 8.7 K or Selling General Administrative of 8.7 M, as well as many indicators such as Price To Sales Ratio of 7.6 K, Dividend Yield of 0.0 or PTB Ratio of 1.16. Atossa financial statements analysis is a perfect complement when working with Atossa Genetics Valuation or Volatility modules.
  
Check out the analysis of Atossa Genetics Correlation against competitors.
For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.

Latest Atossa Genetics' Ebitda Growth Pattern

Below is the plot of the Ebitda of Atossa Genetics over the last few years. It is Atossa Genetics' EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Atossa Genetics' overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Atossa Ebitda Regression Statistics

Arithmetic Mean(14,071,590)
Coefficient Of Variation(67.83)
Mean Deviation7,555,253
Median(12,289,531)
Standard Deviation9,544,801
Sample Variance91.1T
Range30.3M
R-Value(0.91)
Mean Square Error17.1T
R-Squared0.83
Slope(1,939,055)
Total Sum of Squares1275.4T

Atossa Ebitda History

2024-29.8 M
2023-31.4 M
2022-27.7 M
2021-20.5 M
2020-14.6 M
2019-17.2 M
2018-11.4 M

About Atossa Genetics Financial Statements

Atossa Genetics shareholders use historical fundamental indicators, such as Ebitda, to determine how well the company is positioned to perform in the future. Although Atossa Genetics investors may analyze each financial statement separately, they are all interrelated. The changes in Atossa Genetics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Atossa Genetics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
EBITDA-31.4 M-29.8 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Atossa Stock Analysis

When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.